A guide to antigen processing and presentation

2022/04/13 by Novalia Pishesha, Thibault J. Harmand, Hidde L. Ploegh · 19 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Immunotherapy and Immune Responses #T-cell and B-cell Immunology #vaccines and immunoinformatics approaches

paper · doi:10.1038/s41577-022-00707-2

crossref issued 2022/04/13 · crossref published 2022/04/13 · crossref published-online 2022/04/13 · openalex publication_date 2022/04/13 · crossref created 2022/04/13 · crossref published-print 2022/12/01 · crossref deposited 2023/02/01 · openalex created_date 2025/10/10 · crossref indexed 2026/07/28 · openalex updated_date 2026/07/29

Citations

• Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
• Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

Cited by

• Human cytomegalovirus deploys molecular mimicry to recruit VPS4A to sites of virus assembly
• Human cytomegalovirus deploys molecular mimicry to recruit VPS4A to sites of virus assembly
• Retracted and Replaced: Telomere-to-telomere genome and resequencing of 254 individuals reveal evolution, genomic footprints in Asian icefish, Protosalanx chinensis
• A general system for targeting MHC class II–antigen complex via a single adaptable loop
• Molecular determinants of immunogenic cell death elicited by radiation therapy
• A Versatile Polymer‐Based In Situ Nanovaccine to Boost Cancer Immunotherapy
• Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike’s S2 subunit
• Strategies to overcome low MHC-I expression in paediatric and adult tumours
• LSMTCR: A Scalable Multi-Architecture Model for Epitope-Specific T Cell Receptor de novo Design
• CD101: A versatile molecule associated with immunoregulatory and antimicrobial functions
• Dendritic Cells: Origin, Classification, Development, Biological Functions, and Therapeutic Potential
• HLA-E as an Emerging Checkpoint and Biomarker in Personalized Cancer Immunotherapy
• Pan-prediction of major histocompatibility complex class II–restricted epitopes across species via an AlphaFold-based quantification scheme
• Endogenous antigen processing promotes mRNA vaccine CD4 + T cell responses
• Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer
• mRNA-LNP vaccines against Hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models
• Targeting peptide antigens using a multiallelic MHC I-binding system
• Spatial dynamic modelling to understand how dendritic cell clustering affects T cell activation
• Chenodeoxycholic acid restrains tumor growth via TGR5-dependent type 1 dendritic cells cross-priming